Drug design success propels efforts to fight HIV with a combination of 2 FDA-approved drugs

Scientists have developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus. The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy.

Read the whole article on Science Daily

More from Science Daily